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Abstract
Exposure to uncontrolled irradiation in a radiologic terrorism scenario, a natural disaster or a nuclear battlefield, will likely be
concomitantly superimposed on other types of injury, such as trauma. In the central nervous system, radiation combined
injury (RCI) involving irradiation and traumatic brain injury may have a multifaceted character. This may entail cellular and
molecular changes that are associated with cognitive performance, including changes in neurogenesis and the expression
of the plasticity-related immediate early gene Arc. Because traumatic stimuli initiate a characteristic early increase in
polyamine metabolism, we hypothesized that treatment with the polyamine inhibitor alpha-difluoromethylornithine
(DFMO) would reduce the adverse effects of single or combined injury on hippocampus structure and function.
Hippocampal dependent cognitive impairments were quantified with the Morris water maze and showed that DFMO
effectively reversed cognitive impairments after all injuries, particularly traumatic brain injury. Similar results were seen with
respect to the expression of Arc protein, but not neurogenesis. Given that polyamines have been found to modulate
inflammatory responses in the brain we also assessed the numbers of total and newly born activated microglia, and found
reduced numbers of newly born cells. While the mechanisms responsible for the improvement in cognition after DFMO
treatment are not yet clear, the present study provides new and compelling data regarding the potential use of DFMO as a
potential countermeasure against the adverse effects of single or combined injury.
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Introduction
Uncontrolled exposure to radiation presents challenges unlike
those encountered in a clinical situation, i.e. radiotherapy. The
quality of radiation and dose homogeneity will likely be uncertain,
and there will likely be a wide range of delivered doses and
subsequent tissue/body effects. In addition, radiation effects might
be complicated by other types of injury (trauma, burns, infection,
etc.) that either occur at the time of irradiation or at some time
thereafter. Given the growing worldwide threat of radiological/
nuclear terrorism, a natural disaster or a nuclear battlefield, the
concept of radiation combined injury (RCI) has been identified as
a high priority research area [1]. While laboratory and some
human data are available regarding whole body radiation
exposure alone [2], there is a paucity of information regarding
the magnitudes and mechanisms underlying the interactions
between irradiation and other forms of injury, particularly in the
central nervous system (CNS), or if the resultant damage can be
prevented or ameliorated.
In the CNS, severe tissue injury generally occurs only after
exposure to high radiation doses [3]. However, doses that do not
induce significant tissue injury may predispose the brain to a
higher vulnerability to a second insult, like trauma. One type of
injury that can be induced by relatively low doses of irradiation,
and that may be exacerbated in a RCI scenario, is cognitive injury
or deficits in behavioral performance. In humans and animals,
cognitive changes after irradiation alone or trauma alone often
involve changes in hippocampus-dependent learning and spatial
information processing [4–14]. While the mechanisms responsible
for such changes are not well understood, they are likely
multifactorial and may involve altered neurogenesis [8,15–18]
and the expression of the plasticity-related behaviorally-induced
immediate early gene Arc (activity-regulated cytoskeleton-associat-
ed protein) [19,20].
Naturally occurring polyamines (PAs: spermine, spermidine and
putrescine) are essential polycations widely distributed in living
organisms [21]. PAs have a variety of functions, including
modulation of membrane receptor complexes and several
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transient increases in the PAs are a hallmark cellular response to
various traumatic stimuli, and in the brain this may have a
neuroprotective effect under certain circumstances. However, in
the case of a persistent PA alterations such as those seen after some
types of injury, like irradiation [25,26], traumatic brain injury
[27,28], ischemia [29,30], and lipopolysaccharide-induced inflam-
mation [31], changes in brain PA response can be detrimental,
leading to increased neuronal vulnerability [22].
In the brain, traumatic stimuli initiate a characteristic early
increase in PA metabolism (i.e. the PA stress response) that is
considered to be an integral component of a defensive cellular
stress program [22,23]. Increased PA catabolism with concomitant
disruption of PA homeostasis has been shown to lead to a
neurotoxic environment contributing to secondary injury after
traumatic brain injury, and it was suggested that improved
functional recovery may be associated with changes in PA
metabolism [32]. The decarboxylation of ornithine to putrescine
by the cytosolic enzyme ornithine decarboxylase (ODC) is the first
and rate-limiting step in the polyamine biosynthetic pathway [33].
ODC is highly expressed in the hippocampal dentate gyrus [34]
and is upregulated after traumatic brain injury [28]. Chronic oral
administration of alpha-difluoromethylornithine (DFMO), an
irreversible inhibitor of ODC, has been shown to reduce
putrescine levels after a number of different treatment paradigms
and to reduce specific morphologic and inflammatory changes in
the brain that are associated with radiation injury [25,26,35,36].
Currently there are no effective medical treatments to improve
functional outcomes after traumatic brain injury [32]. Whereas an
uncontrolled radiation exposure will result in a wide range of
doses, we purposely, and arbitrarily, selected a relatively low whole
body radiation dose that would not by itself cause radiation
lethality. The present study represented a proof of concept study to
determine if DFMO would modify the behavioral consequences of
single insults or RCI. Considerable data are available showing that
DFMO depletes PA levels [37–39], but for this study we focused
exclusively on how DFMO affects factors associated with
cognition.
Results
First, a DFMO toxicity study was performed. Animals that
received vehicle (plain drinking water) only showed an average
percentage weight gain of 18.664.7 (mean6SEM, n=3) over the
8-week study period. Animals that received DFMO in drinking
water showed average percentage weight changes of 14.665.3,
3.561.0, and 24.161.6 after 1%, 1.5% and 2% DFMO,
respectively. There were no differences in blood cell profiles
among the various groups (not shown). Animals that received
either 1.5% or 2% DFMO experienced seizure-type activity when
placed in the Morris water maze, while mice that received vehicle
or 1% DFMO for 8 weeks showed no hyperactivity or seizures.
Given the potential toxicity associated with an 8-week treatment
with 1.5% or 2% DFMO, we chose the lowest DFMO dose (1%)
for this study. Additionally we restricted total DFMO treatment
time to 42 days, beginning immediately after injury and stopping
two days prior to initiation of the cognitive testing (Fig. 1). After 42
days, and relative to sham treated mice that were treated with
DFMO, the average percentage change in body weight across all
injury groups was less than 5%; no animals in any group showed
hyperactivity or seizure activity.
Radiation alone, trauma alone and RCI, with or without
DFMO, were well tolerated by all animals. The controlled cortical
impact model of traumatic brain injury is widely preferred because
it generates many of the motor and cognitive impairments seen in
TBI patients [40]. In the open head model, a portion of the skull is
removed, and an impacting rod is driven into the dura to produce
deformation of the cortex. Increasing the depth and velocity of the
impact intensifies cortical cavitation as well as deficits in motor and
behavioral function [41,42]. The chosen impact depth (1.0 mm)
used here was based on the previous studies performed in young
adult mice where a 0.50 mm deformation produced mild injury, a
1.0 mm deformation produced moderate injury, and a 2.0 mm
deformation produced severe injury [42].
In our study of moderate traumatic brain injury there was
transient foreleg weakness in some animals; those effects subsided
after 1-2 days. A cavitary cortical lesion was observed at the site of
injury as previously described [13], and in most cases, the
hippocampus proper was completely intact or showed only slight
deformation. In all cases, the dentate gyrus was intact (data not
shown).
Cognitive testing was performed 6 weeks after injury (radiation,
trauma or RCI). With respect to swim speed during the visible
platform sessions there was an irradiation x DFMO treatment
interaction (F=6.674, p=0.002), with DFMO affecting swim
speeds in sham but not in irradiated mice. While sham animals
treated with DFMO swam slower than sham animals treated with
vehicle (F=11.715, p=0.013; vehicle: 14.7 6 0.4 cm/sec;
DFMO: 12.4 6 0.5 cm/sec), such differences were not observed
when animals received irradiation (F=0.067, p=0.797). In
contrast to irradiation alone, there were no effects of trauma
alone, trauma alone + DFMO, RCI, or RCI + DFMO on swim
speeds (data not shown).
Differences in swim speeds across groups could contribute to
potential differences in time to locate the visible platform (latency),
which is a measure of task learning. Therefore, mean swim speed
during the visible session was included as a covariate in the
analysis. During the visible sessions, there was an effect of DFMO
treatment on latency to the target (F=4.511, p=0.039) and a
radiation x DFMO treatment interaction (F=7.155, p=0.010).
While sham mice treated with DFMO required less time to locate
the visible platform location than vehicle treated sham mice
Figure 1. Experimental time line. Two-month-old C57BL/6 mice received whole body irradiation (4 Gy) and immediately after (,15 min) received
either controlled cortical contusion injury or sham craniotomy. Two weeks after injury animals were injected daily for 5 days with BrdU (100 mg/kg).
DFMO was made available in the drinking water immediately upon recovery from surgery and for a total of 42 days and was stopped two days before
cognitive testing in the Morris water maze. Animals were euthanized 30 minute after the last probe trial.
doi:10.1371/journal.pone.0031094.g001
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difference in the time required to locate the visible platform
between irradiated animals treated with DFMO and irradiated
mice treated with vehicle (F=0.067, p=0.797). There were no
effects of trauma alone, RCI, trauma + DFMO, or RCI + DFMO
in terms of latency (data not shown).
For analysis of the hidden platform sessions, which measures
spatial learning, we used the mean swim speed covariate also used
during the visible platform sessions. There was a session x
radiation x DFMO treatment interaction (F=2.873, p=0.015),
mainly driven by an effect in sham-treated animals. When the
sham-treated mice were analyzed separately, there was a session x
DFMO treatment interaction (F=2.293, p=0.034), suggesting
that at least in sham animals the effect of DFMO was not
consistent across all testing sessions. The DFMO effect was most
obvious in session 7, the first session on the second day, i.e. after
the first probe trial (F=8.885, p=0.006). In that session, DFMO-
treated sham mice required more time to locate the hidden
platform location (vehicle: 12.1 6 2.3 sec; DFMO: 23.0 6
2.8 sec). This might be due to a DFMO-induced memory
impairment. However, this could also be due to the effects from
the first probe trial in which the animals might have learned there
was no escape platform. There was also an effect of trauma on the
mean latency across the hidden sessions (F=6.364, p=0.015),
because injured mice required more time to locate the hidden
platform location than sham animals (sham-injury: 15.1 6 1.1 sec;
trauma: 19.1 6 1.0 sec). Together, these data showed that DFMO
affected the swim speeds and the time required to locate the visible
and hidden platform locations in sham but not in irradiated mice.
Significant group differences were revealed during the probe
trial (memory retention task) following the first day of hidden
platform training (Fig. 2). Sham animals treated with vehicle
showed spatial memory retention and spent more time in the
target quadrant than any other quadrant (F=9.336, p=0.0003).
In contrast, there was no preference for the target quadrant in any
of the injury groups (Fig. 2). Similar patterns were seen in terms of
the percentages of mice spending more time in the target quadrant
than any other quadrant (Fig. 3), i.e. spatial bias. This latter
analysis also showed that in the vehicle treated mice, the fraction
of mice showing spatial bias after irradiation only and RCI was
higher than that in the trauma only group.
Sham animals that received DFMO showed spatial memory
retention in the first probe trial similar to what was seen in sham
treated mice that were treated with vehicle (Fig. 2). That is, they
Figure 2. Spatial memory retention in the probe trial following the first day of hidden platform training. *p,0.05 or smaller versus any
other quadrant. For details about the overall effect of quadrant and posthoc tests in individual groups, see text. Number of mice per experimental
group: Control: n=7; TBI: n=8, Irradiation: n=8, TBI/Irradiation: n=8; DFMO control: n=6; DFMO/TBI: n=6; DFMO/Irradiation: 5; DFMO/TBI/
Irradiation: n=6.
doi:10.1371/journal.pone.0031094.g002
Figure 3. Percentage of mice that spent more time in the target quadrant than any other quadrant. For details, see text. Number of mice
per experimental group: Control: n=7; TBI: n=8, Irradiation: n=8, TBI/Irradiation: n=8; DFMO control: n=6; DFMO/TBI: n=6; DFMO/Irradiation: 5;
DFMO/TBI/Irradiation: n=6.
doi:10.1371/journal.pone.0031094.g003
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(F=15.124, p,0.0086). Mice that received trauma + DMFO
(F=4.367, p=0.0161), irradiation + DMFO (F=10.77,
p=0.0004) or RCI + DFMO (F=9.904, p=0.0006), all showed
preference to the target quadrant, in contrast to what was seen in
vehicle treated groups (Fig. 2). Relative to what was seen in
vehicle treated animals, DFMO treatment increased the number
of mice showing spatial bias in the trauma only and radiation only
groups (Fig. 3).
During subsequent probe trials, there were no significant
differences between sham-treated mice and mice that received
trauma alone, irradiation alone, or RCI, whether or not they
received DFMO (not shown). Thus, with sufficient additional
training the spatial memory retention seen following just one day
of hidden platform training could be overcome.
Injury or DFMO treatment did not affect the average number
of neurons in the dentate gyrus. In terms of the fractions of
neurons expressing Arc protein, there was a significant interaction
between drug treatment and injury (F(1,57)=4.17, p#.01) (Fig. 4),
with a significant effect of injury type in vehicle-treated
(F(3,25)=3.12, p,0.04) but not in animals treated with DFMO.
In vehicle-treated mice, post-hoc analyses showed significant
reductions in the fraction of Arc+ neurons after trauma only
(p,0.009) and RCI (p,0.02), but not after irradiation alone
(Fig. 4). In the contralateral hemisphere of animals that received
injury plus vehicle, the numbers of neurons expressing Arc protein
were slightly but not significantly reduced relative to sham mice
(not shown). In the contralateral hemisphere of animals that
received injury plus DFMO, the numbers of neurons expressing
Arc protein were slightly but not significantly higher relative to
sham mice (not shown).
The presence of BrdU+ cells 4 weeks after BrdU injection
represents the long-term survival of newly generated cells,
independent of phenotype. Similar to what was seen for the Arc
data described above, there was an interaction between drug
treatment and injury in the ipsilateral hemisphere for BrdU+ cells
(F(1,57)=3.38, p#.02), with a significant effect of injury type in
vehicle-treated but not in animals treated with DFMO. (Fig. 5).
There also was an effect of treatment alone (p,0.001) and of
injury alone (p,0.001) on this endpoint (Fig. 5). In animals
treated with vehicle, there was no difference in numbers of BrdU+
cells between sham-treated controls and mice that received trauma
only or radiation only, with the numbers averaging 488689,
517659, and 417650, respectively. However, after RCI the
numbers of BrdU+ cells averaged 726650 (p=0.05, Fig. 5). In
contrast to animals treated with vehicle, animals that received
DFMO showed no differences in the total number of BrdU+ cells
as a function of treatment, with all groups averaging about 150
BrdU+ cells. Because all DFMO groups had reduced BrdU counts
relative to the corresponding vehicle groups, these data suggested
that a drug dose of 1% had cytostatic effects independent of
treatment. In the contralateral hemisphere we saw the same
pattern as seen in the ipsilateral side (not shown).
In terms of newly born neurons (BrdU+/NeuN+) in the
ipsilateral hemisphere, there were no significant effects of insult
alone or drug alone (Fig. 6). With respect to newly born astrocytes
(BrdU/GFAP+), there were effects of DFMO (p,0.001) and
injury type (p,0.0001) on the numbers of cells in the dentate SGZ
in the ipsilateral hemisphere (Fig. 7). DFMO reduced the number
of newly born astrocytes as compared to the vehicle treatment. In
addition, mice that received RCI had higher numbers of newly
born astrocytes than sham or irradiated mice. In the contralateral
hemisphere, such differences were not seen.
In mice that were treated with vehicle or DFMO there were no
group differences seen in either hemisphere in terms of total
number of activated microglia (CD68 only) (not shown). DFMO
(p,0.019) and injury (p,0.0001) had an effect on newly born
microglia (BrdU+/CD68+) in the ipsilateral hemisphere (Fig. 8).
DFMO reduced the number of newly born microglia as compared
to the vehicle treatment. In addition, mice that received
RCI6DFMO had higher numbers of newly born microglia than
sham, trauma, or irradiated mice.
Discussion
The results of this study showed that: a) single and combined
injuries induced variable degrees of hippocampus-dependent
Figure 4. Percentages of hippocampal granule cell expressing
Arc protein 30 min after the last probe trail of the Morris water
maze. Two-way ANOVA revealed a significant interaction between
drug treatment (DFMO vs vehicle) and injury (trauma, radiation, RCI).
Animals treated with vehicle after trauma or RCI showed a significant
reduction in the percentage of neurons expressing Arc relative to sham
treated animals (#p,0.009, * p,0.02). There was no difference in the
percentage of neurons expressing Arc between the different injury
groups in the DFMO treated animals. Each treatment group consisted of
8–11 mice. Each bar represents a mean value and error bars are SEM.
doi:10.1371/journal.pone.0031094.g004
Figure 5. Total number of BrdU positive cells in the dentate
subgranular zone. There was a significant interaction between drug
treatment and injury. RCI animals treated with vehicle showed a
significantly higher number of total BrdU compared to sham control
animal (*p,0.05). In animals treated with DFMO there was no
differences in the total number of BrdU positive cells among the
different injury group. Each treatment group consisted of 8–11 mice.
Each bar represents a mean value and error bars are SEM.
doi:10.1371/journal.pone.0031094.g005
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effects; b) measurements of the plasticity-related immediately early
gene Arc were consistent with the cognitive findings; and c)
neurogenesis per se may not be a critical factor in the changes in
cognitive performance with or without DFMO. Given there are
virtually no data available addressing the concept of combined
radiation and traumatic brain injury and how factors associated
with long term behavioral performance are affected in such a
scenario, the present study provides new and compelling data
regarding the potential use of DFMO in this context. We
recognize that a potential countermeasure against RCI will
probably be administered some time post exposure, after adequate
triage mechanisms have been implemented. However, laboratory
studies such as this one need to be performed first to determine if a
given agent has any promise at all against single or RCI.
Treatment with 1% DFMO for a total of 42 days did not induce
any adverse effects in terms of body weight or blood cell profiles,
suggesting the compound was minimally toxic. However, the
finding that sham animals treated with DFMO swam slower than
animals treated with vehicle indicates there were some physical
decrements induced by prolonged treatment with the drug. The
fact that irradiation resolved or prevented this effect is interesting
but not yet understood. The same type of paradoxical effect was
seen in the hidden platform sessions. This suggested that DFMO
might induce a learning impairment that was reversed after
irradiation. The significance of these effects and how they
develop is not known, but their magnitude does not indicate a
significant toxicity associated with chronic DFMO treatment.
Other investigators have previously addressed potential adverse
effects of chronic DFMO treatment on cognition [43,44], and it
was concluded that acute or chronic DFMO treatments might
have very different behavioral effects [44]. Chronic DFMO
treatment for 54 days was reported to affect spatial learning and
memory in rats, but that study used a much higher concentration
of DFMO in the drinking water (3%) than used in the present
study.
Hippocampus dependent cognitive impairments were quanti-
fied using the Morris water maze [45] and a paradigm involving a
probe trial at the end of each day of multiple hidden platform
training sessions [46]. In animals that received vehicle, only sham-
treated mice showed significant preference for the target quadrant
in the first probe trial, and animals that received trauma only were
most affected (Fig. 2). Analysis of spatial bias, which quantifies the
proportion of mice in a given group that exhibit spatial memory
retention, clearly showed mice that received trauma alone were
the most seriously affected (Fig. 3). Those changes were not seen
in subsequent probe trials suggesting that even cognitively
impaired animals could successfully perform the water maze task
with additional training. This latter finding highlights the strength
of using multiple probe trials in the design of the water maze task,
a result previously reported in the assessment of RCI [20] and
after irradiation of mice expressing different human apoE isoforms
[47] or mice lacking the gene for extracellular superoxide
dismutase [46].
The present data showed that DFMO had a significant positive
effect in terms of the retention of spatial memory. Regardless of
injury type, all animals that received DFMO showed significant
preference to the target quadrant, (Fig. 2). Analysis of spatial bias
Figure 7. Total number of BrdU/GFAP positive cells per mm
2 in
the dentate subgranular zone. Overall, there was no interaction
between drug (DFMO, vehicle) and treatment (trauma, radiation, RCI);
however, independently both DFMO (p,0.001) and injury type
(p,0.0001) had significant effects on the numbers of newly born
astrocytes in the dentate SGZ. Each treatment group consisted of 8–11
mice. Each bar represents a mean value and error bars are SEM.
doi:10.1371/journal.pone.0031094.g007
Figure 8. Total number of BrdU/CD68 (activated microglia)
positive cells per mm
2 in the dentate subgranular zone. Overall,
there was no interaction between drug (DFMO, vehicle) and treatment
(trauma, radiation, RCI); however, independently both DFMO (p,0.019)
and injury type (p,0.0001) had significant effects on the numbers of
newly born microglia. Each treatment group consisted of 8–11 mice.
Each bar represents a mean value and error bars are SEM.
doi:10.1371/journal.pone.0031094.g008
Figure 6. Total number of BrdU/NeuN positive neurons per
mm
2 in the dentate subgranular zone. Overall, there was no
significant interaction between treatment and drug and no effect of the
treatment alone or drug alone. In control mice treated with vehicle
trauma alone induced no changes while radiation alone decreased the
number of BrdU+/NeuN+ cells in the ipsilateral hemisphere. Animals
from the RCI group showed an increase in the numbers of newly born
neurons compared to radiation alone. Each treatment group consisted
of 8–11 mice. Each bar represents a mean value and error bars are SEM.
doi:10.1371/journal.pone.0031094.g006
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reversed cognitive impairment after all injuries. Changes in spatial
bias between vehicle-treated and DFMO-treated mice were
particularly obvious after trauma alone. These findings, while
representing only one DFMO dose and treatment schedule,
suggest that further studies of this agent are warranted to
determine its usefulness as a potential countermeasure for single
and combined injuries.
There are a variety of factors that may impact or influence the
development or severity of cognitive impairment seen after single
or combined injuries. Three of these, Arc expression, neurogenesis
and neuroinflammation, have been used previously to assess how
irradiation affects factors associated with cognitive performance
with or without traumatic brain injury [19,20,48,49]. Gene
expression associated with learning and memory produces de novo
synthesis of proteins, like Arc, which alter synaptic strength and
are essential for memory processes [50–53]. Arc expression plays
an important role in the neuroplastic mechanisms critical to
memory consolidation [54], and inhibition of Arc protein
expression impairs the consolidation of long-term memory during
Morris water maze testing [55]. Therefore, the significant
reduction of Arc expression seen here in vehicle-treated animals
that experienced trauma alone and RCI (Fig. 4), may partially
explain the inability of the animals to properly recall the location
of the platform during the first probe trial (Fig. 2).
However, the absolute number of neurons expressing Arc is
not a simple predictor of cognitive performance. Sham treated
mice that received DFMO had significantly fewer Arc+ neurons
when compared to sham treated mice that received vehicle, yet
the cognitive performances of those groups were comparable
(Fig. 2). Whether the reduction in the number of neurons
expressing Arc in DFMO treated animals represents a simple
‘resetting’ of the system to a lower baseline level or indicates that
Arc expression is not an adequate predictor of cognitive
performance is not known. However, the markedly different
pattern of Arc expression in the various DFMO treatment groups
(trauma, irradiation, RCI) relative to that seen in groups
receiving vehicle, suggests that it is the former rather than the
latter. That is, after injury plus DFMO, where the average
fractions of Arc+ cells were higher than their sham-controls, there
was an overall improvement in cognitive performance compared
to injury plus vehicle, where cognitive performances were
impaired and the average fractions of Arc+ cells injury groups
were lower than their sham-control.
Another factor that has been associated with cognitive
performance is hippocampal neurogenesis, and data exist showing
that neurogenic cells in the hippocampus are very radiosensitive,
and are reduced by doses that are below the threshold for the
lethal hematopoeitic or gastrointestinal radiation syndromes
[8,15–18]. Furthermore, changes in neurogenesis are associated
with hippocampal dependent behavioral deficits [5–10,20,56–58].
Because traumatic brain injury shares specific neuropathologic
characteristics with ionizing irradiation (i.e. reduced neurogenesis,
reduced Arc expression, inflammation, hippocampal-dependent
cognitive impairment) [11–14,20], the impact of the separate
stimuli may work in concert to cause more injury than would be
expected by a simple summation of effects. The relationship
between neurogenesis and cognitive function is complicated and
very well could be context-dependent, that is, it may differ
depending upon the experimental conditions being investigated
[20].
With respect to the numbers of newly generated cells,
independent of phenotype (i.e. BrdU+ only), only mice that were
treated with vehicle and received RCI showed any significant
change relative to controls or other treatments (Fig. 5). Animals
that received irradiation only had fewer BrdU+ cells but that
change was not significant. DFMO significantly reduced BrdU
labeling in all treatment groups to about the same level, a finding
consistent with the known cytostatic effects of the compound [59].
In terms of newly born neurons (BrdU+/NeuN+) there were no
significant differences across treatments in mice that received
either vehicle or DFMO. The trend toward a decrease after
irradiation plus vehicle and an increase in RCI plus vehicle,
appeared to be change after DFMO treatment, but the
magnitudes and lack of significance precludes any definitive
conclusions. Given that, the data suggest that the generation of
newly born neurons per se may not be a critical factor in the
changes in cognitive performance observed here, a finding in
support of a previous report on RCI [20].
There were generally fewer newly born astrocytes in the dentate
SGZ in animals treated with DFMO than in mice treated with
vehicle, and in both treatment groups the numbers of cells were
significantly affected by injury type (Fig. 7). It will require further
study to understand the implications associated with these
changes, and if they are relevant to behavioral performance.
Given that polyamines have been found to modulate
inflammatory responses in the brain [31], and inflammation
has been shown to affect neurogenesis [15,60–63] and Arc
expression after irradiation [19], we hypothesized that DFMO
may affect cognitive performance after single or combined
treatment via changes in neuroinflammation. We monitored
inflammatory changes by quantifying numbers of microglia, a
cell type commonly assessed as a measure of neuroinflammation
after radiation exposure [15,60–63]. While there were no
differences across treatment and injury groups with respect to
total numbers of activated microglia, there were generally fewer
newly born (BrdU+) activated microglia after DFMO treatment
when compared with animals treated with vehicle (Fig. 8). While
these results are compatible with a generalized reduction of
inflammation in DFMO-treated mice, the data are not sufficient
to made definitive conclusions. Additional studies, and in
particular the measurement of more factors associated with
inflammation, are required to determine if the overall effects of
DFMO on cognitive performance are mediated by inflammatory
processes.
The mechanisms responsible for the improvement in cognition
after DFMO treatment are not yet clear, and future studies will be
required to determine if those effects are mediated by, or
independent of, actual polyamine levels in the hippocampus.
Nonetheless, the fact that such a reversal is observed, particularly
after trauma, is noteworthy and potentially very important.
Further studies with DFMO are needed to determine not only
its potential usefulness in managing traumatic brain injury alone
but also its potential as a countermeasure against RCI.
Methods
Ethics statement
Mice were housed and cared for in compliance with the United
States Department of Health and Human Services Guide for the
Care and Use of Laboratory Animals and institutional IACUCs.
Seventy-two male C57BL/6 mice (Jackson Laboratory, Bar
Harbor, ME), 2 months old, were used. Twelve mice were used for
a pilot DFMO dosing study and the rest of the animals in each
injury paradigm were randomly distributed into 2 cohorts, that
received either regular drinking water (vehicle) or water with 1%
DFMO. Within each cohort there were 4 treatment categories: 0
Gy/sham surgery (Sham, n=19), 4.0 Gy/sham surgery (Radia-
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(RCI, n=14). Animals were group housed (4 mice/cage)
throughout the study. Mice were maintained on a 12-h light-dark
cycle, and irradiations, induction of trauma and behavioral testing
were done during the light period. All procedures (sham surgery,
trauma and irradiation) were performed between 10 am and 2 pm,
and all behavioral training and testing were done on all animals at
the same time of day. All animals were provided food and water ad
libitum.
Irradiation and Traumatic Brain Injury
Whole body irradiation of unanesthetized mice was done using
a
137Cs irradiator (Gamma Cell 3000, MDS Nordion Inc., Ottawa
Ontario, Canada). Animals were irradiated individually in a
specially designed restrainer that fit into the irradiator and allowed
animals to minimally move around. Dosimetry was performed
using film exposure within the cesium irradiator under the same
geometry used for the animal treatments. The film readings were
calibrated against a range of doses obtained using a linear
accelerator. The dose chosen for this study was 4.0 Gy, a dose that
does not induce significant changes in the gut or bone marrow in
mice. The total time of irradiation was approximately 1 minute.
Immediately after irradiation, mice were anesthetized with 4%
isoflurane. Anesthesia was maintained via a non-rebreathing
apparatus connected to a nose cone on the stereotaxic head frame
(Kopf, Tujunga, CA). Ointment was applied to the eyes to protect
vision, and heads were shaved with an electric clipper. The skin
was prepped with betadine ointment, and a midline incision was
made through the scalp. A circular craniotomy, 3.5 mm in
diameter was made in the left parietal skull between the bregma
and lambda, 0.5 mm lateral to the midline. The skullcap was
carefully removed without disruption of the dura. All mice,
regardless of injury type, were subjected to this surgical procedure.
Mice that were randomly selected for the trauma only (no
irradiation) or RCI treatment groups were subjected to a
controlled cortical impact ([13,20]. The lesion was produced with
a pneumatic impact device using a 3-mm-diameter convex tip,
mounted 20
0 from the vertical to account for the curvature of the
skull. The contact velocity was set at 4.5 m/s with a deformation
1.5 mm below the dura, producing a moderately severe lesion to
the cortex without encroaching on the hippocampus. After the
procedure, the scalp was sutured and each animal received a
subcutaneous injection of warm physiologic saline (1 ml) to
prevent dehydration. During surgery and subsequent recovery,
body temperature was maintained with a circulating water heating
pad.
DFMO Treatment
DFMO was generously provided by Dr. Victor A. Levin.
DFMO is stable in drinking water for prolonged period of time
(months) providing there is no growth or contamination by
microorganisms (V. Levin, personal communication). A large
number of studies are available showing that DFMO can be given
in this manner, and is effective at concentrations ranging from
0.5–3% [31,38,64–66]. It has been reported that such chronic
treatment with DFMO can induced strain-dependent hyperactive
behavior and seizure activity upon additional stimulation (e.g.
noise) [67]. Thus, we performed an initial dose ranging study in
small groups of uninjured mice to determine the dose to be used in
our subsequent RCI study. Groups of three mice received either
vehicle, or 1%, 1.5% or 2% (w/v) DFMO dissolved in drinking
water. The DFMO solutions were changed weekly. To assess
general health of animals, mice were weighed 26/week for 8
weeks, and water maze training and testing was initiated to
determine if DFMO affected behavioral performance. Blood was
obtained at 8 weeks when the animals were euthanized.
Once the DFMO treatment dose was established (i.e. 1%),
single or combined treatments were initiated either with or without
drug. The DFMO was administered as described above. DFMO
was made available to the mice immediately upon their recovery
from surgery and for a total of 42 days (Fig. 1). DFMO treatment
was stopped during the 5 days of cognitive testing.
BrdU Injection
Fourteen days following sham injury or traumatic brain injury,
all mice received daily injections of BrdU (100 mg/kg) for 5
consecutive days. Four weeks after the first BrdU injection mice
underwent Morris water maze training and testing and then they
were euthanized and tissues were collected for analysis of
neurogenesis and Arc protein expression (Fig. 1).
Morris Water Maze
Assessment of hippocampus-dependent cognitive performance
was started 6 weeks after irradiation, trauma or RCI using the
Morris water maze test as previously described [20,68]. Briefly, a
circular pool (diameter 140 cm) was filled with opaque water
(24uC) and mice were trained to locate a platform (luminescence:
200 lux). To determine if treatment affected the ability to swim or
learn the water maze task, mice were first trained to locate a
clearly marked platform (visible platform, Days 1 and 2). Mice
were subsequently trained to locate the platform when it was
hidden beneath the surface of the opaque water (Days 3–5).
Hidden platform training (acquisition) required the mice to learn
the location of the hidden platform based on extra-maze cues.
For both visible and hidden platform paradigms, there were 2
daily sessions which were 2 hr apart. Each session consisted of 3
trials (with 10-min inter-trial intervals). A trial ended when the
mice located the platform. Mice that failed to locate the platform
within 60 sec were lead to the platform by placing a finger in
front of their swim path. Mice were taken out of the pool after
they were physically on the platform for a minimum of 3 sec.
During visible platform training, the platform was moved to a
different quadrant of the pool for each session. For the hidden
platform training, the platform location was kept constant. Mice
were placed into the water facing the edge of the pool in one of 9
randomized locations. The start location was changed for each
trial. Swimming patterns were recorded with the Noldus
Ethovision video tracking system (Ethovision XT, Noldus
Information Technology, Wageningen, Netherlands) set at 6
samples/second. The time to locate the platform (latency) was
used as a measure of performance for the visible and hidden
sessions.
To measure spatial memory retention, probe trials (platform
removed) were conduced 1 hr after the last trial on each day of
hidden platform training (i.e. 3 separate probe trials). For the
probe trials, mice were placed into the water in the quadrant
opposite from the target quadrant. The time spent in the target
quadrant, i.e. where the platform was previously located during
hidden platform training, was compared to the time spent in the 3
non-target quadrants. In addition, the percentage of mice from
each experimental cohort that spent more time in the target
quadrant than any other quadrant was calculated.
After the last probe trial, mice were returned to their home
cages. Thirty min later, mice were killed by cervical dislocation
and decapitated. The 30 min interval was chosen because at that
time, behaviorally induced Arc protein can be detected within the
DG [19,20]. Brains were removed quickly (within 60 sec) and
frozen in 270uC isopentane.
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The brains from multiple animals were blocked together and
cryosectioned [19,20] such that each slide contained sections
from one animal from each of the experimental conditions:
Sham, Radiation, Trauma, and RCI. All slides were stored at
270uC until processed for immunocytochemical analysis. Brain
sections were taken from the medial portion of the dorsal
hippocampus (anteroposterior ,2.92–4.0 mm from bregma).
Quantitative assessment of Arc protein was performed using
methods previously reported by us in detail [19,20,52]. Tissue
sections were fixed in 2% paraformaldehyde, and after blocking
with a tyramide signal amplification kit (TSA; PerkinElmer Life
Science, Emeryville, CA), they were incubated in polyclonal
rabbit anti-Arc antibody for 48 h at 4uC, (1:500; rabbit anti-Arc
a gift from Paul F. Worley, Johns Hopkins University School of
Medicine, Baltimore, MD). Sections were then incubated with
an anti-rabbit biotinylated secondary antibody (Vector Labora-
tories) for 2 h at room temperature, followed by amplification
with an avidin-biotin system for 45 minutes. Staining was
reveled using a cyanine-3 (CY3) TSA fluorescence system
(PerkinElmer).
Microscopic imaging for Arc protein was performed at 206
magnification using a Zeiss AXIO IMAGER Z1 microscope with
motorized Z-drive for transmitted light and epi-fluorescence [19].
For each endpoint, two coronal sections per mouse were randomly
selected from the dorsal hippocampus (1.7 to 2.3 mm posterior
from Bregma) and used to reconstruct mosaics of the ipsilateral
and contralateral DG. Each mosaic was formed from 6–8 Z-stack
(1.0 mm optical thickness/plane) images.
To determine if irradiation, traumatic brain injury and/or
combined injury resulted in variations in granule cell density, the
numbers of cells per mm
2 were counted from selected regions of
the ipsilateral DG in one representative section from each animal
in the study.
Arc-positive neurons had perinuclear-cytoplasmic staining
surrounding the cell and visible in at least three plains together
with the cell nucleus across the z-stack [19,20,52]. To avoid
classification errors, we carefully verified that the staining
belonged to the cell of interest by checking the nuclear
counterstaining. The numbers of Arc positive neurons/mm
2
characterized by these criteria were determined in the enclosed
and free blades of the DG [19,20,52]. We then calculated the
percentage of neurons expressing Arc protein for each animal
[19,52]. The only studies involving Arc and cognitive performance
after irradiation and traumatic brain injury have been restricted to
the DG [19,20]. Given that the kinetics of Arc expression in the
DG is different from the other hippocampal subfields [51], and
because they have not yet been characterized in mice, in the
current study we restricted our analysis to the DG.
To determine the effects of single or combined treatment on
the survival of newly born cells in the dentate subgranular zone
(SGZ), sections were prepared as above and immunostained as
previously described [15,16]. Newly born cells were stained
using rat anti-BrdU (1:10; Oxford Biotechnology, Kidlington,
Oxford, UK), neuronal cells were stained with biotinylated
mouse anti-NeuN (1:200; Chemicon, Temecula, CA, USA), as-
trocytes with anti-glial fibrillary acidic protein (GFAP, Pharmi-
gen, San Diego, CA, USA), and activated microglia with anti-
CD68 (Sertotec Inc., Raleigh, NC); cell specific staining was
revealed respectively with Texas red (Vector, Burlingame, CA)
and Alexa Fluor 499 or 594 (Molecular Probes, Eugene, OR,
USA).
To calculate the numbers of BrdU-positive (BrdU+) cells in the
SGZ, 12 sections of a one-in-six series were scored per animal
[16]. All counts were limited to the dentate granule cell layer and a
50 mm border along the hilar margin that included the SGZ; cell
counts were obtained for both hemispheres. BrdU+ cells displaying
the various lineage-specific phenotypes were counted in two
representative sections and the values converted to numbers of
cells/mm
2.
Statistics
Water maze performance was analyzed using SPSS software
using repeated measures ANOVAs to compare visible and hidden
water maze learning curves (radiation, trauma, RCI, and
treatment as between subjects factors and session as within
subjects factor). Tukey-Kramer post hoc tests were used when
appropriate. For analysis of performance in the water maze probe
trials, one-way ANOVAs were used along with Dunnett’s posthoc
tests comparing each non-target quadrant to the target quadrant.
Statistical analyses for the immunohistochemistry cell counts were
performed using GraphPad Prism software (La Jolla, CA 92037
USA). Two-way ANOVA was used to test the main effects of
treatment (DFMO or vehicle) and injury (radiation, trauma or
RCI and potential interaction between treatment and injury).
When the interaction between injury and treatment was significant
(p,0.05), a step-down procedure for multiple comparisons would
follow with two separate one-way ANOVAs. Different injuries or
treatments were used as the independent variables and the
percentages of cells from each category described above as the
dependent variables. When the overall ANOVA was significant
(p,0.05), individual between-groups comparisons were performed
with Bonferroni post hoc to correct for multiple comparisons. Data
for the ipsilateral and contralateral hemispheres were analyzed
separately [20].
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